Analyst Ratings For Allied Minds PLC (LON:ALM)
Today, Credit Suisse Group lowered its price target on Allied Minds PLC (LON:ALM) to GBX 111 per share.
There are 1 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Allied Minds PLC (LON:ALM) is Buy with a consensus target price of GBX 119.50 per share, a potential .
Some recent analyst ratings include
- 1/17/2017-Allied Minds PLC (LON:ALM) had its Buy rating reiterated by Whitman Howard with a GBX 480 price target
About Allied Minds PLC (LON:ALM)
Allied Minds plc is a private equity and venture capital firm specializing in pre-seed, seed, start-up, and early stage technology investments. The firm prefers to invest across all products, services, and industries with a focus on the life science and technology sector including medical devices, diagnostics, biopharmaceuticals, big data, cyber security, communications, semiconductors, and food safety. It primarily invests in companies based in the United States, but depending on opportunities this could be expanded to a global network of partners and investments. The firm typically invests between $0.25 million and $1 million in seed investments and from $5 million to $10 million in Series A investments. The firm focuses on commercializing technologies from leading United States Universities and national labs. It seeks to take majority equity positions in its portfolio companies. The firm partners with universities to fund licensing deals and corporate spin-outs. It prefers to continue to invest alongside a syndicate for larger Series A and follow-on rounds. Allied Minds plc is based in Boston, Massachusetts with additional offices in London, United Kingdom; Los Angeles, California; Seattle, Washington; New York; New York and Washington, DC.
Recent Trading Activity for Allied Minds PLC (LON:ALM)
Shares of Allied Minds PLC closed the previous trading session at 71,00 0,00 0,00 % with shares trading hands.